Rossari Biotech Share Price Today (ROSSARI)
TODAY IN ONE LINE
ROSSARI slipped 0.6% on light volume, in line with Nifty's 0.3% move, supported by recent strong earnings.
With a market cap of ₹2,797.28 Cr., it trades at a P/E of 18.60. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Rossari Biotech flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 33.5% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 18.2% and Profit up 33.5%
- ●Reasonable ValuationTrading at a moderate P/E of 19.6x
- ●High Promoter HoldingPromoters hold 68.2% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest Rossari Biotech News
What changed recently?
Recent events, corporate actions, and announcements.
Rossari Biotech Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Rossari Biotech Limited, framed against the sector median so the premium or discount is obvious at a glance.
Rossari Biotech Limited trades at a P/E of 18.60× and P/B of 2.10×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Rossari Biotech Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Rossari Biotech Limited — derived from the live tape, not yesterday's close.
Rossari Biotech Limited last traded at ₹504.3 with an intraday range of ₹503.2–₹514 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹504.30| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 532.73 | +28.43 | +5.64% |
| R3 | 521.93 | +17.63 | +3.50% |
| R2 | 517.97 | +13.67 | +2.71% |
| R1 | 511.13 | +6.83 | +1.36% |
| PIVOT | 507.17 | 2.87 | 0.57% |
| CURRENT | 504.30 | — | — |
| S1 | 500.33 | -3.97 | -0.79% |
| S2 | 496.37 | -7.93 | -1.57% |
| S3 | 489.53 | -14.77 | -2.93% |
| S4 | 478.73 | -25.57 | -5.07% |
ROSSARI is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹505.6–₹514
Trading Below opening range, showing Bearishness
Rossari Biotech Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Rossari Biotech Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Rossari Biotech Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹2,797.28 Cr. and reported EPS of ₹26.91.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 2,080 | 2,396 ▲ 15.2% |
| Sales Growth YoY %Derived | 13.64% | 15.19% |
| Other Income | 4 | 22 ▲ 458.2% |
| Total Income | 2,084 | 2,419 ▲ 16.0% |
| 1,433 | 1,669 ▲ 16.4% | |
| Gross ProfitDerived | 647 | 728 ▲ 12.5% |
| Gross Margin %Derived | 31.10% | 30.36% |
| 382 | 442 ▲ 15.7% | |
| EBITDA (Operating Profit)Derived | 265 | 286 ▲ 7.9% |
| OPM %Derived | 12.74% | 11.93% |
| 85 | 108 ▲ 26.8% | |
| Profit Before Tax (PBT) | 184 | 201 ▲ 8.9% |
| 49 | 53 ▲ 9.2% | |
| Effective Tax %Derived | 26.50% | 26.57% |
| Total Profit for Period | 136 | 149 ▲ 9.4% |
| Less: Non-controlling Interests | — | — |
| Net Profit (Owner's PAT)Derived | 136 | 149 ▲ 9.4% |
| Net Profit Margin %Derived | 6.56% | 6.23% |
| PAT Growth YoY %Derived | 4.35% | 9.41% |
| Earnings Per Share (EPS ₹) | 24.63 | 26.94 ▲ 9.4% |
| Diluted Shares Outstanding (Cr) | 6 | 6 ▲ 0.0% |
| Share of Profit from Associates/JVs | 1 | 2 ▲ 94.4% |
| Other Comprehensive Income (Net of Tax) | -1 | 0 ▲ 107.4% |
| Total Expenses (incl. D&A & Interest) | 1,900 | 2,218 ▲ 16.7% |
| Material Cost % of RevenueDerived | 62.47% | 66.92% |
| Employee Cost % of RevenueDerived | 6.36% | 6.46% |
| Other Cost % of RevenueDerived | 12.00% | 11.98% |
| Interest Coverage (x)Derived | 11.12x | 7.24x |
| Period | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | 709 | 1,483 ▲ 109.1% | 1,656 ▲ 11.7% | 1,831 ▲ 10.5% | 2,080 ▲ 13.6% | 2,396 ▲ 15.2% | |
| Sales Growth YoY %Derived | — | 109.06% | 11.66% | 10.55% | 13.64% | 15.19% | |
| Other Income | 9 | 12 ▲ 30.5% | 5 ▼ 54.3% | 7 ▲ 35.8% | 4 ▼ 46.2% | 22 ▲ 458.2% | |
| Total Income | 719 | 1,495 ▲ 108.1% | 1,661 ▲ 11.1% | 1,838 ▲ 10.6% | 2,084 ▲ 13.4% | 2,419 ▲ 16.0% | |
462 | 1,105 ▲ 139.1% | 1,171 ▲ 6.0% | 1,294 ▲ 10.4% | 1,433 ▲ 10.8% | 1,669 ▲ 16.4% | ||
| Gross ProfitDerived | 247 | 378 ▲ 52.9% | 485 ▲ 28.2% | 537 ▲ 10.8% | 647 ▲ 20.5% | 728 ▲ 12.5% | |
| Gross Margin %Derived | 34.84% | 25.48% | 29.26% | 29.34% | 31.10% | 30.36% | |
124 | 194 ▲ 56.7% | 262 ▲ 34.5% | 287 ▲ 9.8% | 382 ▲ 32.9% | 442 ▲ 15.7% | ||
| EBITDA (Operating Profit)Derived | 123 | 183 ▲ 49.1% | 223 ▲ 21.6% | 250 ▲ 12.0% | 265 ▲ 6.1% | 286 ▲ 7.9% | |
| OPM %Derived | 17.35% | 12.37% | 13.47% | 13.64% | 12.74% | 11.93% | |
26 | 61 ▲ 135.1% | 85 ▲ 40.4% | 80 ▼ 6.4% | 85 ▲ 6.4% | 108 ▲ 26.8% | ||
| Profit Before Tax (PBT) | 106 | 135 ▲ 26.6% | 143 ▲ 6.3% | 177 ▲ 23.9% | 184 ▲ 3.8% | 201 ▲ 8.9% | |
27 | 39 ▲ 44.0% | 37 ▼ 4.2% | 47 ▲ 27.0% | 49 ▲ 4.0% | 53 ▲ 9.2% | ||
| Effective Tax %Derived | 25.17% | 28.64% | 25.80% | 26.45% | 26.50% | 26.57% | |
| Total Profit for Period | 80 | 98 ▲ 22.0% | 107 ▲ 9.8% | 131 ▲ 21.8% | 136 ▲ 4.4% | 149 ▲ 9.4% | |
| Less: Non-controlling Interests | -0 | 0 ▲ 112.1% | — ▼ 100.0% | — | — | — | |
| Net Profit (Owner's PAT)Derived | 80 | 98 ▲ 21.8% | 107 ▲ 9.8% | 131 ▲ 21.8% | 136 ▲ 4.4% | 149 ▲ 9.4% | |
| Net Profit Margin %Derived | 11.31% | 6.59% | 6.48% | 7.14% | 6.56% | 6.23% | |
| PAT Growth YoY %Derived | — | 21.76% | 9.81% | 21.85% | 4.35% | 9.41% | |
| Earnings Per Share (EPS ₹) | 15.45 | 17.74 ▲ 14.8% | 19.45 ▲ 9.6% | 23.66 ▲ 21.6% | 24.63 ▲ 4.1% | 26.94 ▲ 9.4% | |
| Diluted Shares Outstanding (Cr) | 5 | 6 ▲ 6.0% | 6 ▲ 0.2% | 6 ▲ 0.2% | 6 ▲ 0.2% | 6 ▲ 0.0% | |
| Share of Profit from Associates/JVs | 0 | 2 ▲ 276.4% | 1 ▼ 38.1% | 0 ▼ 81.7% | 1 ▲ 458.9% | 2 ▲ 94.4% | |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▼ 19.8% | 0 ▲ 252.9% | 0 ▼ 97.0% | -1 ▼ 11488.9% | 0 ▲ 107.4% | |
| Total Expenses (incl. D&A & Interest) | 612 | 1,360 ▲ 122.2% | 1,518 ▲ 11.6% | 1,661 ▲ 9.4% | 1,900 ▲ 14.4% | 2,218 ▲ 16.7% | |
| Material Cost % of RevenueDerived | 61.30% | 65.42% | 65.17% | 67.19% | 62.47% | 66.92% | |
| Employee Cost % of RevenueDerived | 5.92% | 4.58% | 5.96% | 5.63% | 6.36% | 6.46% | |
| Other Cost % of RevenueDerived | 11.58% | 8.53% | 9.84% | 10.06% | 12.00% | 11.98% | |
| Interest Coverage (x)Derived | 33.50x | 10.70x | 7.17x | 9.78x | 11.12x | 7.24x |
Rossari Biotech segment analysis : revenue and profit mix.
Disclosed business segments at Rossari Biotech with their share of revenue and profit, switchable between consolidated and standalone reporting.
Rossari Biotech discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Rossari Biotech Limited.
Our AI distills the core fundamental drivers supporting Rossari Biotech Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Rossari Biotech Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Latest quarterly EPS grew 33.5% YoY, reflecting robust earnings acceleration.
Strong ROE 11.85% and ROCE 15.80% demonstrate efficient capital deployment.
Low debt-to-equity ratio 0.10x with minimal total debt signals financial stability.
Promoter holding 68.15% indicates strong insider confidence and long-term commitment.
Undervalued P/E 19.60x sits 40% below sector median, offering attractive entry valuation.
Key Risks.
Operating margin 11.90% quarterly, below peer median 13.73%, pressures profitability.
FII holdings eased from 8.51% to 3.48%, signaling foreign investor caution.
Dividend yield 0.10% minimal, unattractive for income-focused investors.
Operating cash flow ₹58.73 Cr significantly below PAT ₹142.84 Cr, weak cash conversion.
Free cash flow negative ₹42.67 Cr FY26 despite positive earnings, concerning trend.
Flip Conditions.
Valuation risk. a P/E above 24 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Rossari Biotech Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Rossari Biotech Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Rossari Biotech Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Rossari Biotech Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Rossari Biotech Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Rossari Biotech Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Rossari Biotech Limited stood at 63.0% of traded volume, against a 20-day average of 49.4%.
Rossari Biotech announcements: results, concalls, ratings, M&A.
Filings Rossari Biotech sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Rossari Biotech files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 127 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Intimation of Transcript of Q1 FY 27 for the Earnings Conference Call held on July 20, 2026.
Shareholders meeting
Outcome of 17th Annual General Meeting of the Members of the Company along with Proceedings, Voting Results and Scrutinizers Report.
Analysts/Institutional Investor Meet/Con. Call Updates
Audio recording of Earnings Conference Call for Q1 FY 27.
Press Release
Rossari Biotech Limited informed the Exchange regarding Press Release dated July 18, 2026 titled " Rossari Biotech announces Q1 FY 27 results".
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Rossari Biotech dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Rossari Biotech has declared, sequenced by announce and record date.
Rossari Biotech corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Rossari Biotech Limited: business, sector, key facts.
What Rossari Biotech Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Rossari Biotech Limited operates in the Specialty Chemicals industry under the Chemicals sector, listed as NSE: ROSSARI, BSE: 543213.
Rossari Biotech Limited is a prominent Indian manufacturer and seller of specialty chemicals, serving both domestic and international markets. Their diverse portfolio encompasses a wide range of applications, showcasing their extensive capabilities within the chemical industry. This breadth allows them to cater to various sectors, demonstrating adaptability and a strategic focus on multiple revenue streams. The company's operational structure is built on a foundation of manufacturing and direct sales, giving them direct control over the production process and market access.
A significant portion of Rossari's business is dedicated to the production and distribution of chemicals for the soap and detergent industry. This is a substantial market segment, and Rossari's presence indicates their competitiveness and ability to meet the demands of this sector. Beyond detergents, they supply chemicals for inks, paints, coatings, ceramics, tiles, pulp and paper production, and cement manufacturing, highlighting the versatility of their chemical offerings and their significant contribution to several essential industrial processes.
Rossari further distinguishes itself through its specialized textile chemical offerings. This segment showcases a deep understanding of the textile industry's diverse needs. They provide chemicals tailored for various fabric types including cotton, polyester, acrylic, wool, silk, and nylon, demonstrating expertise in diverse textile processing techniques. Their commitment extends to functional finishes, denim processing, printing, and environmentally sustainable solutions, reflecting a focus on innovation and meeting contemporary industry demands.
In addition to its industrial chemical production, Rossari has expanded into consumer goods with its line of pet grooming products. These products, marketed under the brands Lozalo, Hunger Fills, and Sniffy, include shampoos, powders, deodorants, sprays, creams, and floor washing liquids. This diversification demonstrates a strategy to broaden their market reach and tap into consumer demand for pet care products. The company also produces poultry nutrition products, including vitamin-mineral formulations, enzyme blends, and herbal supplements, indicating expansion into the agricultural sector and the growing market for animal nutrition.
Founded in 1997 and headquartered in Mumbai, Rossari Biotech has evolved significantly since its inception as Rossari Labtech. The company's continuous growth and diversification illustrate a commitment to innovation, market expansion, and a strong understanding of various industry needs. Their success hinges on their ability to adapt to market trends and deliver high-quality chemical solutions for various sectors, ranging from industrial manufacturing to consumer products.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Aarti Industries (AARTIIND) Share PricePeer
- Aarti Surfactants (AARTISURF) Share PricePeer
- Archean Chemical Industries (ACI) Share PricePeer
- Aether Industries (AETHER) Share PricePeer
- Alkali Metals (ALKALI) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Rossari Biotech Limited (ROSSARI).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Rossari Biotech Limited (ROSSARI)?
The current share price of Rossari Biotech Limited (ROSSARI) is ₹504.3. Today, the stock has declined by ₹3.25 (0.64%), trading in a range of ₹503.2 to ₹514. The stock opened at ₹514 with a trading volume of 37,575 shares.
02Is Rossari Biotech Limited stock a good investment for long-term?
Rossari Biotech Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹2,797.28 crores, P/E ratio of 18.60, ROE of 10.80%, and ROCE of 13.30%. The dividend yield stands at 0.10%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Rossari Biotech Limited stock?
The 52-week high price of Rossari Biotech Limited (ROSSARI) is ₹713.1, while the 52-week low is ₹375. Currently trading at ₹504.3, the stock is 38.2% away from its 52-week low and 29.3% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Rossari Biotech Limited stock at the current price?
Whether to buy Rossari Biotech Limited stock at ₹504.3 depends on multiple factors. The stock is currently trading with a P/E ratio of 18.60 and P/B ratio of 2.10. Today's performance shows a loss of 0.64%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Rossari Biotech Limited and when is the next dividend?
Rossari Biotech Limited offers a dividend yield of 0.10%, which means for every ₹100 invested at the current price of ₹504.3, you can expect to receive approximately ₹0.10 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Rossari Biotech Limited?
Rossari Biotech Limited's key financial metrics include: P/E Ratio: 18.60, P/B Ratio: 2.10, ROE: 10.80%, ROCE: 13.30%, Dividend Yield: 0.10%, EPS: ₹26.91, Book Value: ₹240.75, and Debt-to-Equity: 0.33. The company's market cap stands at ₹2,797.28 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Rossari Biotech Limited stock performing today in the market?
Rossari Biotech Limited stock opened at ₹514 and is currently trading at ₹504.3, showing a decline of ₹3.25 (0.64%). The intraday high is ₹514 and low is ₹503.2. The trading volume stands at 37,575 shares, indicating moderate market participation today.
08What is the P/E ratio of Rossari Biotech Limited and what does it indicate?
Rossari Biotech Limited has a Price-to-Earnings (P/E) ratio of 18.60, which means investors are willing to pay ₹18.60 for every ₹1 of earnings. With an EPS of ₹26.91, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Rossari Biotech Limited (ROSSARI) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.